Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
Related Posts
Bennett JL, Middaugh N, Yeaman MR, Smith TJ, Behne MK, Crabtree M, McLean RR, Pappas DA, Levy M. SPHERES: innovative registry addressing the new era[...]
Madaras-Kelly KJ, Nakasone T, Maghari S, Taylor J, Nevers M, Crook J, Brintz B, Braunfeld JB, Goetz MB, Samore M. A pilot intervention to improve[...]
Wang Q, Barilar I, Minin VM, Modongo C, Moonan PK, Finlay A, Boyd R, Oeltmann JE, Molefi TL, Zetola NM, Brewer TF, Niemann S, Shin[...]